A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma
Clinical trial NCT06548347 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06548347
- Sponsor
- Shanghai YingLi Pharmaceutical Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2024-12-31
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.